This study provides compelling evidence linking autoimmune diseases such as celiac disease, hyperthyroidism, and hypothyroidism to an increased risk of subsequent development of type 1 diabetes (T1D).

The study design is rigorous, employing propensity score matching to control for confounding variables and conducting several sensitivity analyses to validate the robustness of the findings.

These findings underscore the importance of T1D screening in individuals with these autoimmune conditions and contribute to a better understanding of T1D pathogenesis.

However, several points require clarification or modification:

1. Rationale for Autoimmune Disease Selection:
   Please clarify the rationale for selecting only celiac disease, hyperthyroidism, and hypothyroidism for analysis.

Was this choice driven by prior research indicating a stronger association between these specific autoimmune diseases and T1D compared to others? Or was it primarily based on the existing availability of relevant studies for these conditions?

1. Statistical Analysis Details and Potential Biases:
   Software Specification: The statistical analysis section should explicitly state the statistical software used.

Model Validation: Specifically address whether the Cox proportional hazards model was assessed for multicollinearity and overfitting. Provide details on any methods used to detect and mitigate these potential issues.

Propensity Score Matching Considerations: The manuscript states: "Participants from the autoimmune and control cohorts were then matched 1:1 on propensity scores based on age at index, sex, race, region, index year, and whether they had relatives with T1D."

Please discuss any other potentially relevant variables that should have been included in the propensity score matching but were omitted due to data limitations/availability.

Acknowledge and discuss the potential impact of these unmeasured confounders.

1. Family History and Screening Priorities:
   Given that approximately 90% of individuals with T1D do not have a family history of the disease, this raises the question of whether screening should be prioritized in other high-risk populations beyond those with a family history.

Could the observed association with "relatives with type 1 diabetes" be artificially inflated due to an ascertainment bias or other factors?

Discuss the implications of this finding in the context of broader T1D screening strategies.